Mainline Optimization Phase 1

Business news, market intelligence, and global industry analysis.

The Latest

Representative image of unbranded electric scooters in a factory, illustrating Ola Electric’s QIP fundraise and India’s fast-growing EV two-wheeler market.

Is Ola Electric raising capital at the right time, or just before the next EV squeeze?

Representative image of oncology researchers examining an unbranded clinical sample as Moderna and Merck report durable five-year melanoma data for their personalized mRNA cancer vaccine combined with Keytruda.

Moderna (MRNA) and Merck (MRK) cancer vaccine sustains benefit at five years, but investors stay cautious

Representative image of an unbranded beverage bottling plant with packaged soft drinks, illustrating Coca-Cola’s India IPO plans and the growth of India’s FMCG beverage sector.

Why Coca-Cola’s India IPO plan is really a test of its Campa Cola defence strategy

Lode Resources may have found more than antimony at Montezuma. What does it mean for ASX:LDR investors?

Representative image illustrating North American energy infrastructure, as Enbridge Inc. reports record 2025 results, reaffirms 2026 guidance, and expands its $39 billion secured growth backlog across pipelines, gas, and renewable power.

Enbridge (TSX: ENB; NYSE: ENB) reports record 2025 results, reaffirms 2026 guidance, and expands secured growth backlog to $39bn

Enbridge Inc. reports record 2025 results, reaffirms 2026 guidance, and expands its secured backlog to $39 billion. Find out what this means for investors.

μFR system
αvβ6-integrin
α4β7 integrin
Zywie Ventures
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynga
Zynext Ventures USA LLC
Zynext Ventures

February 15, 2026